Cytokinetics

#药闻简讯# 欧洲药品管理局（CHMP）对$Cytokinetics(CYTK)$ Myqorzo（阿菲卡坦）治疗成人梗阻性肥厚型心肌病给出积极意见。该疾病特征为心脏主要泵血腔室的肌肉增厚或扩大，可能阻碍血液从心脏流向身体其他部位。

$Cytokinetics(CYTK)$ 现在就看12.26FDA审批REMS的轻重了，较轻的REMS会极大压缩$Edgewise(EWTX)$ 生存空间。但$Edgewise(EWTX)$二期数据26年H1出，如果有个好的结果就直接终结市场了。

Cytokinetics的心肌肌球蛋白抑制剂aficamten（阿夫凯泰）已在中国获得全球首个监管批准。该药物在中国以星舒平为商品名销售，将由赛诺菲负责市场推广。该药物用于治疗纽约心脏协会(NYHA)心功能分级II-III级的梗阻性肥厚型心肌病(HCM)成人患者，以改善运动能力和症状。
这项批准距离备受关注的...

$Cytokinetics(CYTK)$ 不声不响来到第一重仓。。。。

$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-007783  Act: 33  Size: 6 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000007  Size: 5 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000009  Size: 7 KB 网页链接

$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-007585  Act: 33  Size: 5 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000036  Size: 4 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000038  Size: 4 KB 网页链接

$Cytokinetics(CYTK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-266842  Act: 34  Size: 473 KB 网页链接

$Cytokinetics(CYTK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-267059  Act: 34  Size: 11 MB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000039  Size: 4 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000040  Size: 11 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000042  Size: 8 KB 网页链接

$Cytokinetics(CYTK)$ 也自动行权了

$Cytokinetics(CYTK)$ 8-K Current report, item 5.02 Accession Number: 0001193125-25-282889  Act: 34  Size: 155 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000026  Size: 8 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000005  Size: 7 KB 网页链接

$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001061983-25-000016  Size: 5 KB 网页链接